流感疫苗的重配病毒：是时候重新审视它们的基因组结构了吗？ - Suppr

Suppr

超能文献

Reassortant viruses for influenza vaccines: is it time to reconsider their genome structures?

作者信息

Isakova-Sivak Irina, Korenkov Daniil, Rudenko Larisa

机构信息

a Department of Virology , Institute of Experimental Medicine , Saint Petersburg , Russia.

出版信息

Expert Rev Vaccines. 2016 May;15(5):565-7. doi: 10.1586/14760584.2016.1158109. Epub 2016 Mar 16.

DOI:10.1586/14760584.2016.1158109

PMID:26924073

Abstract

摘要

相似文献

Reassortant viruses for influenza vaccines: is it time to reconsider their genome structures?流感疫苗的重配病毒：是时候重新审视它们的基因组结构了吗？

Expert Rev Vaccines. 2016 May;15(5):565-7. doi: 10.1586/14760584.2016.1158109. Epub 2016 Mar 16.

Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.用于减毒流感疫苗（LAIV）的亲代病毒 A/Leningrad/134/17/57（H2N2）和 B/USSR/60/69 及其衍生重组病毒在小鼠模型中不表现出神经毒力特性。

Arch Virol. 2010 Sep;155(9):1391-9. doi: 10.1007/s00705-010-0719-8. Epub 2010 Jun 10.

[The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains].[甲型流行性感冒病毒的温度敏感性作为重组疫苗株免疫原性的一个标志物]

Vopr Virusol. 2003 Jul-Aug;48(4):26-9.

Flu in the limelight.流感备受关注。

Vaccine. 2002 May 22;20(17-18):2153-4. doi: 10.1016/s0264-410x(02)00196-2.

[DEVELOPMENT OF THE QUADRIVALENT LIVE ATTENUATED INFLUENZA VACCINE INCLUDING TWO INFLUENZA B LINEAGES--VICTORIA AND YAMAGATA].包含两种B型流感病毒系（维多利亚系和山形系）的四价减毒活流感疫苗的研发

Vopr Virusol. 2016;61(1):16-20.

Development and characterization of a live attenuated influenza B virus vaccine candidate.一种乙型流感病毒减毒活疫苗候选株的研发与特性分析

Vaccine. 2008 Feb 13;26(7):874-81. doi: 10.1016/j.vaccine.2007.12.022. Epub 2008 Jan 7.

H5N1 viruses and vaccines.H5N1病毒与疫苗。

PLoS Pathog. 2007 Mar;3(3):e40. doi: 10.1371/journal.ppat.0030040.

Generation and characterization of candidate vaccine viruses for prepandemic influenza vaccines.大流行前流感疫苗候选疫苗病毒的产生与特性分析

Curr Top Microbiol Immunol. 2009;333:83-108. doi: 10.1007/978-3-540-92165-3_4.

Influenza vaccines: challenges and solutions.流感疫苗：挑战与解决方案。

Cell Host Microbe. 2015 Mar 11;17(3):295-300. doi: 10.1016/j.chom.2015.02.012.

Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.开发欧亚H7N7/PR8高生长重组病毒作为灭活大流行性流感疫苗进行临床评估。

Vaccine. 2008 Mar 25;26(14):1742-50. doi: 10.1016/j.vaccine.2008.01.036. Epub 2008 Feb 13.

引用本文的文献

Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines.核蛋白作为一种有潜力的广泛保护性流感疫苗抗原。

Vaccines (Basel). 2023 Nov 23;11(12):1747. doi: 10.3390/vaccines11121747.

Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein.NS1蛋白的截短增强了表达野生型核蛋白的减毒活流感疫苗病毒的T细胞介导的交叉保护作用。

Vaccines (Basel). 2023 Feb 21;11(3):501. doi: 10.3390/vaccines11030501.

Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model.嵌合A/B型减毒活流感疫苗在小鼠模型中的安全性、免疫原性及保护效力

Microorganisms. 2021 Jan 27;9(2):259. doi: 10.3390/microorganisms9020259.

Construction and identification of influenza plasmid pool imparting high yields to candidate vaccine viruses in Vero cell at low temperature.构建并鉴定流感质粒池，使其能够在低温下在 Vero 细胞中为候选疫苗病毒提供高产量。

J Cell Mol Med. 2020 Oct;24(19):11198-11210. doi: 10.1111/jcmm.15672. Epub 2020 Sep 9.

Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.在雪貂模型中，含有野生型核蛋白的 A(H3N2) 减毒流感活疫苗的安全性、免疫原性和保护效果。

Infect Genet Evol. 2018 Oct;64:95-104. doi: 10.1016/j.meegid.2018.06.019. Epub 2018 Jun 19.

Live Attenuated Reassortant Vaccines Based on A/Leningrad/134/17/57 Master Donor Virus Against H5 Avian Influenza.基于A/列宁格勒/134/17/57主供体病毒的H5禽流感减毒活重配疫苗

Open Microbiol J. 2017 Nov 30;11:316-329. doi: 10.2174/1874285801711010316. eCollection 2017.

Live Attenuated Influenza Vaccines engineered to express the nucleoprotein of a recent isolate stimulate human influenza CD8 T cells more relevant to current infections.经工程改造表达近期分离株核蛋白的活减毒流感疫苗能更有效地刺激人体针对当前感染的流感 CD8 T 细胞。

Hum Vaccin Immunother. 2018 Apr 3;14(4):941-946. doi: 10.1080/21645515.2017.1417713. Epub 2018 Jan 23.

Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.含野生型核蛋白的大流行性H1N1减毒活流感疫苗在小鼠体内的免疫原性和交叉保护作用

Biomed Res Int. 2017;2017:9359276. doi: 10.1155/2017/9359276. Epub 2017 Jan 22.

Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.在小鼠模型中，对含有来自冷适应或野生型流感病毒核蛋白的减毒活流感疫苗的感染性、免疫原性和交叉保护效力进行的比较研究。

Virology. 2017 Jan;500:209-217. doi: 10.1016/j.virol.2016.10.027. Epub 2016 Nov 6.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验